Animal Antibiotics and Antimicrobials market growth at a CAGR of ~ 5.2% from 2021 to 2027
The global Animal Antibiotics and Antimicrobials market gathered revenue around USD 3.5 Billion in 2020 and market is set to grow USD 7.4 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 5.2% during the prediction period 2021 to 2027. Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases. Rising animal healthcare spending and the growing demand for pet insurance are further expected to drive the growth of this market. The untapped emerging markets such as China, India, and Brazil and growth in the overall companion animal population are also expected to offer significant growth opportunities to market players in the coming years
However, the limited number of new antibiotics, growing resistance to antimicrobials and antibiotics, and increasing good husbandry and hygiene practices are expected to hinder the growth of this market to a certain extent.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Animal Antibiotics and Antimicrobials market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Animal Antibiotics and Antimicrobials market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Animal Antibiotics and Antimicrobials market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Asia Pacific recorded the highest CAGR for animal antimicrobials and antibiotics market in 2019
The animal antimicrobials and antibiotics market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 32.4% of the global animal antimicrobials and antibiotics market. The large share of this region is mainly due to the increase in the region’s animal population, rising demand for animal-derived food products, growth in pet insurance, and rising animal health expenditure compared to other regions.
The Asia Pacific region is projected to grow at the highest CAGR of 6.1% during the forecast period. Factors such as the rapidly increasing animal population and rising demand for animal-derived food products are driving the growth of this market in the APAC.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Animal Antibiotics and Antimicrobials Market are:
The major market players include: Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc. (US), Phibro Animal Health (US), Virbac (France), Vetoquinol SA (France), HIPRA (Spain), Ceva Santé Animale (France), Dechra Pharmaceuticals Plc (UK), Kyoritsu Seiyaku (Japan), Tianjin Ringpu (China), China Animal Husbandry (China), Endovac Animal Health (US), Zydus (India), Indian Immunologicals Pvt. Ltd. (India), UCBVET (US), American Reagent Inc. (US), Neogen Corporation (US), Huvepharma Inc. (US), Ayurvet (India), Ashish Life Science (India), Inovet (Belgium), Lutim Pharma (India), and ECO Animal Health (US).
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Type of Product
By Mode of Delivery
By Animal Type
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Benefits For Stakeholders
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Animal Antibiotics And Antimicrobials Market, By Type of Product
7.1. Animal Antibiotics And Antimicrobials Market, By Type of Product, 2021-2027
7.1.1. Tetracyclines
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Penicillins
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Sulfonamides
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Macrolides
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Aminoglycosides
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Lincosamides
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Fluoroquinolones
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Cephalosporins
7.1.8.1. Market Revenue and Forecast (2016-2027)
7.1.9. Other Antimicrobials and Antibiotics
7.1.9.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Animal Antibiotics And Antimicrobials Market, By Mode of Delivery
8.1. Animal Antibiotics And Antimicrobials Market, by Mode of Delivery, 2021-2027
8.1.1. Premixes
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Oral Powder
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Oral Solution
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Oral Solution
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Animal Antibiotics And Antimicrobials Market, By Animal Type
9.1. Animal Antibiotics And Antimicrobials Market, by Animal Type, 2021-2027
9.1.1. Food-Producing Animals
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Companion Animals
9.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Animal Antibiotics And Antimicrobials Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.1.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.1.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.1.4.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.1.5.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.2.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.2.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.2.4.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.2.5.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.2.6.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.2.7.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.3.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.3.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.3.4.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.3.5.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.3.6.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.3.7.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.4.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.4.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.4.4.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.4.5.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.4.6.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.4.7.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.5.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.5.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.5.4.3. Market Revenue and Forecast, by Animal Type (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Type of Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Mode of Delivery (2016-2027)
10.5.5.3. Market Revenue and Forecast, by Animal Type (2016-2027)
Chapter 11. Company Profiles
11.1. Boehringer Ingelheim
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Zoetis Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Elanco Animal Health
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Merck & Co. Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Phibro Animal Health
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Virbac
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Vetoquinol SA
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. HIPRA
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Ceva Santé Animale
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Dechra Pharmaceuticals Plc
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers